The latest price and purchasing methods of Glecaprevir/pibrentasvir tablets (Glecaprevir/pibrentasvir) in 2025

Glecaprevir/pibrentasvir is a fixed-dose combination drug used to treat hepatitis C virus (HCV). It contains Glecaprevir and pibrentasvir and is effective against all six types of hepatitis C. At 12 weeks after treatment, hepatitis C virus was undetectable in 81% to 100% of patients, demonstrating its good efficacy. This medication is usually taken by mouth once daily with food.

Common side effects in patients taking glecaprevir and pibrentasvir tablets include headache, diarrhea and fatigue. In addition, patients with a history of hepatitis B may be at risk of HBV reactivation, so caution is required when prescribing. This drug is not recommended for patients with moderate to severe liver disease to avoid aggravating the condition.

The original drug of glecaprevir and pibrentasvir tablets has been launched in China, but it has not yet been included in the scope of medical insurance reimbursement, resulting in a relatively high price. This is a combination preparation. A box of 21 tablets of glecaprevir and pibrentasvir tablets in China sells for about RMB 10,000. In overseas markets, the specifications of the European version of the original drug are 100mg/40mg*84 tablets, and the price per box may reach 120,000 yuan (the price may fluctuate due to the exchange rate), which is very expensive.

Currently, there are no generic versions of glecaprevir and pibrentasvir tablets available for purchase at home and abroad, further limiting patients’ choices and economic burden. Therefore, when considering treatment options, patients should fully understand their own situation and financial affordability, and consult their doctors for advice in order to choose the most appropriate treatment option. At the same time, patients can also purchase them through overseas hospitals or pharmacies to ensure the legality and safety of the drugs.

In short, glecaprevir and pibrentasvir tablets are an effective treatment for hepatitis C, but factors such as price, medical insurance coverage, and possible side effects must be considered before use.

Reference materials:https://www.mavyret.com/